Literature DB >> 30883832

Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: A study of three different doses of 810 nm laser.

Emad Eshaghi1,2, Saeed Sadigh-Eteghad1, Gisou Mohaddes1, Seyed Hossein Rasta1,2,3,4.   

Abstract

OBJECTIVES: The effectiveness of transcranial photobiomodulation (TPBM) in treating anxiety and depression disorders is a demonstrated and identified issue. However, the optimum therapeutic dose and the underlying mechanism of action are not fully understood. In this study, the therapeutic effects of three different near-infrared (NIR) doses on anxiety- and depression-like behaviors as well as cerebral levels of serotonin (5-HT) and nitric oxide (NO) were evaluated in a mouse model of chronic restraint stress (CRS).
MATERIALS AND METHODS: CRS procedure (3 hours/day, over 3 weeks) was performed as a typical stress model to study anxiety and depression along with laser treatment (3 times/week, over 3 weeks), which began simultaneously with CRS. A NIR diode laser (810 nm wavelength, 10 Hz) with the output power of 200 mW and power density of 4.75 W/cm2 was implemented to deliver three different doses of 4, 8, and 16 J/cm2 to the cerebral cortex of mice. Behavioral experiments including open field, tail suspension, and elevated plus maze tests as well as serum cortisol levels were assessed to evaluate the anti-anxiety and anti-depressive effects of NIR TPBM. The changes of 5-HT and NO levels in the prefrontal cortex (PFC) and hippocampus (Hipp) were assessed.
RESULTS: CRS procedure induced anxiety- and depression-like behaviors, increased serum cortisol levels, decreased 5-HT and increased NO levels in the PFC and Hipp areas. NIR TPBM improved behavioral results, decreased serum cortisol levels, increased 5-HT and decreased NO concentrations in the PFC and Hipp. A dose of 8 J/cm2 of NIR TPBM showed the maximum effects on behavioral and molecular results, while a decline was observed from the optimum effects at both lower (4 J/cm2 ) and higher (16 J/cm2 ) doses.
CONCLUSION: Our results demonstrated that NIR TPBM had an anti-anxiety and anti-depressive effect in CRS mice, which is probably linked to increasing 5-HT and decreasing NO levels in the PFC and Hipp areas. Also, the maximum anti-anxiety and anti-depressive effect was produced at dose of 8 J/cm2 . Lasers Surg. Med.
© 2019 Wiley Periodicals, Inc. © 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety; depression; dose-response; near-infrared; nitric oxide; serotonin; transcranial low-level light/laser therapy; transcranial photobiomodulation

Year:  2019        PMID: 30883832     DOI: 10.1002/lsm.23082

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  11 in total

1.  Transcranial Photobiomodulation with Near-Infrared Light for Generalized Anxiety Disorder: A Pilot Study.

Authors:  Marco Maiello; Olivia M Losiewicz; Eric Bui; Vincenza Spera; Michael R Hamblin; Luana Marques; Paolo Cassano
Journal:  Photobiomodul Photomed Laser Surg       Date:  2019-10

Review 2.  St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Authors:  Gita Kholghi; Shirin Arjmandi-Rad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-16       Impact factor: 3.000

3.  Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression.

Authors:  Haitham S Mohammed; Yasser A Khadrawy
Journal:  Lasers Med Sci       Date:  2021-09-06       Impact factor: 3.161

4.  Suppressive Effects of Gelsemine on Anxiety-like Behaviors Induced by Chronic Unpredictable Mild Stress in Mice.

Authors:  Hui Yu; Mo-Huan Tang; Zi-Yue Zeng; Si-Juan Huang; Xiao-Feng Zheng; Zhao-Ying Liu
Journal:  Brain Sci       Date:  2022-01-30

Review 5.  Mechanistic aspects of photobiomodulation therapy in the nervous system.

Authors:  Fatemeh Ramezani; Ali Neshasteh-Riz; Alireza Ghadaksaz; Seyedalireza Moghadas Fazeli; Atousa Janzadeh; Michael R Hamblin
Journal:  Lasers Med Sci       Date:  2021-02-24       Impact factor: 3.161

6.  Low-Level Laser Therapy in Prevention of the Development of Endothelial Dysfunction and Clinical Experience of Treatment and Rehabilitation of COVID-19 Patients.

Authors:  Sergey Moskvin; Evgeniy Askhadulin; Andrey Kochetkov
Journal:  Rehabil Res Pract       Date:  2021-01-26

7.  Effects of prenatal photobiomodulation treatment on neonatal hypoxic ischemia in rat offspring.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Hannah Youngblood; Yong Li; Xuemei Zong; Lei Li; Tongda Xu; Quanguang Zhang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

8.  Transcranial Laser Therapy Does Not Improve Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast Injury.

Authors:  Georgina Perez Garcia; Gissel M Perez; Alena Otero-Pagan; Rania Abutarboush; Usmah Kawoos; Rita De Gasperi; Miguel A Gama Sosa; Dylan Pryor; Patrick R Hof; David G Cook; Sam Gandy; Stephen T Ahlers; Gregory A Elder
Journal:  Neurotrauma Rep       Date:  2021-12-02

9.  A Novel Treatment of Opioid Cravings With an Effect Size of .73 for Unilateral Transcranial Photobiomodulation Over Sham.

Authors:  Fredric Schiffer; William Reichmann; Edward Flynn; Michael R Hamblin; Hannah McCormack
Journal:  Front Psychiatry       Date:  2020-08-19       Impact factor: 4.157

10.  Transcranial Photobiomodulation (tPBM) With 1,064-nm Laser to Improve Cerebral Metabolism of the Human Brain In Vivo.

Authors:  Tyrell Pruitt; Xinlong Wang; Anqi Wu; Elisa Kallioniemi; Mustafa M Husain; Hanli Liu
Journal:  Lasers Surg Med       Date:  2020-03-15       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.